Why the study?
How are plasma levels of ADH and neurophysin altered in patients with chronic renal failure, and how does hemodialysis affect them?
How are plasma levels of ADH and neurophysin altered in patients with chronic renal failure, and how does hemodialysis affect them?
In patients with chronic renal failure, plasma levels of ADH and neurophysin are significantly elevated, likely due to decreased turnover, and ADH secretion remains primarily regulated by effective plasma osmolality.
Answers are grounded in this paper and cite their sources.
Elevated ADH and neurophysins in chronic renal failure with HD responses are hypothesis-generating; prospective studies needed before clinical consideration.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Hasegawa et al. (1986) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: